Internal Medicine · Kissimmee, FL
NPI
1750341236
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
1032 Mann Street, Oak Medical Plaza 1
Kissimmee, FL, 34741
Phone (407) 518-7277
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
1,438 services
Medicare patients, 2024
131
Average age 62
Drug cost, 2024
$1.5M
11,367 prescriptions
Company payments, 2025
$238
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ajaz Afzal was code 99213 (office e&m - established), 569 times for 95 patients. In total Ajaz Afzal billed 1,438 services in 32 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-02.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 569 | 95 | $66.49 | $38K |
| 99214 Office E&M - Established | Office | 333 | 97 | $89.88 | $30K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 177 | 73 | $47.63 | $8,430 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 93 | 60 | $35.52 | $3,304 |
| 80307 Drug Tests | Office | 43 | 24 | $60.90 | $2,619 |
| 99211 Office E&M - Established | Office | 28 | 26 | $15.26 | $427 |
| 36415 Venipuncture Blood Collection | Office | 14 | 14 | $8.65 | $121 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 11 | 11 | $125.70 | $1,383 |
By year: 2022 $138K for 2,460 services; 2023 $78K for 1,311 services; 2024 $86K for 1,438 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 43 | 24 | $60.90 | $2,619 |
| 36415 Venipuncture Blood Collection | 14 | 14 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug Ajaz Afzal prescribed most often to Medicare patients was Gabapentin, with 319 prescriptions and refills. In total Ajaz Afzal wrote 11,367 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 319 | 365 | 93 | $3,942 |
| Alprazolam Generic | 272 | 272 | 64 | $889 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 233 | 275 | 79 | $4,445 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 212 | 212 | 55 | $5,678 |
| Mounjaro Tirzepatide | 211 | 221 | 40 | $235K |
| Lidocaine Generic | 208 | 230 | 48 | $24K |
| Zolpidem Tartrate Generic | 196 | 196 | 44 | $1,411 |
| Azithromycin Generic | 184 | 184 | 115 | $477 |
| Ibuprofen Generic | 179 | 187 | 68 | $2,501 |
| Amlodipine Besylate Generic | 172 | 315 | 62 | $600 |
| Pantoprazole Sodium Generic | 169 | 291 | 67 | $728 |
| Diclofenac Sodium Generic | 165 | 171 | 57 | $10K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 163 | 189 | 48 | $122K |
| Ondansetron Odt Ondansetron | 162 | 169 | 46 | $6,128 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 157 | 157 | 41 | $3,555 |
Brand drugs: 1,786 claims; generic drugs: 9,459 claims; opioid claims: 680.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ajaz Afzal $238 ($238 in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $42.74.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 2 | $42.74 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $34.87 |
| Braeburn Inc. | 1 | $26.73 |
| Axsome Therapeutics, Inc. AXSM | 1 | $21.89 |
| Idorsia Pharmaceuticals US Inc | 1 | $20.81 |
| Novo Nordisk Inc NVO | 1 | $17.04 |
| Evoke Pharma, Inc. EVOK | 1 | $15.53 |
| GlaxoSmithKline, LLC. GSK | 1 | $15.09 |
| Abbvie Inc. ABBV | 1 | $14.83 |
| Lundbeck LLC | 1 | $14.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.